News
- Author:
- Mark S. Lesney, PhD
Publish date: October 17, 2022
Sepsis survivors discharged to post-acute care facilities are at high risk.
News
- Author:
- Mark S. Lesney, PhD
Publish date: August 9, 2022
Three new and still-recruiting trials of interest to pulmonologists and their patients are presented in this debut presentation of Clinical Trials ...
News
- Author:
- Mark S. Lesney, PhD
Publish date: June 15, 2022
Individuals who self-reported having poor-quality sleep had a 25%-95% higher risk of COPD exacerbations.
News
- Author:
- Mark S. Lesney, PhD
Publish date: June 3, 2022
“We need to find out how well approved asthma drugs work for disadvantaged children of color living in urban areas.”
News
- Author:
- Mark S. Lesney, PhD
Publish date: May 10, 2022
To update its 2016 recommendation, the U.S. Preventive Services Task Force commissioned a reaffirmation evidence ...
News
- Author:
- Mark S. Lesney, PhD
Publish date: March 16, 2022
The approval was given for a metered-dose inhaler that contains both budesonide and formoterol.
News
- Author:
- Mark S. Lesney, PhD
Publish date: December 20, 2021
“Tezspire represents a much-needed new treatment for the many patients who remain underserved and continue to struggle with severe, uncontrolled as...
News
- Author:
- Mark S. Lesney, PhD
Publish date: October 5, 2021
“Careful observation is needed in patients with hemophilia even after eradication of HCV.”
News
- Author:
- Mark S. Lesney, PhD
Publish date: September 28, 2021
The observed rates of intracranial hemorrhaging (ICH) in patients with hemophilia were higher compared to the gen...
News
- Author:
- Mark S. Lesney, PhD
Publish date: September 23, 2021
Hypomethylation of the asparagine synthase gene was significantly associated with poor therapeutic outcome in children with T-cell acute lymphoblas...
News
- Author:
- Mark S. Lesney, PhD
Publish date: September 20, 2021
Most other outcomes were similar for patients with and without CLL, including mortality and infection.
News
- Author:
- Mark S. Lesney, PhD
Publish date: September 15, 2021
Overall, 3 of the 12 patients showed a response after pembrolizumab: One complete response; two partial responses...
News
- Author:
- Mark S. Lesney, PhD
Publish date: September 9, 2021
A genetically induced shift toward higher lymphocyte counts was found to increase susceptibility to childhood acu...
News
- Author:
- Mark S. Lesney, PhD
Publish date: September 8, 2021
Reduced expression of thrombomodulin caused by the gene variant may be responsible for the disseminated intravasc...
News
- Author:
- Mark S. Lesney, PhD
Publish date: August 26, 2021
BCR-ABL mutation tyrosine kinase inhibitors have transformed Ph+ ALL from an historically poor prognosis disease ...
